Novolin GE Toronto is a short-acting human insulin (rDNA origin) supplied at 100 IU/mL in a 10 mL vial. Intended for subcutaneous administration, it supports antidiabetic treatment plans as directed by a healthcare professional. Each mL provides 100 IU, with non-medicinal ingredients including zinc chloride, glycerol, metacresol, sodium hydroxide and/or hydrochloric acid, and water for injections. DIN 02024233. The compact vial format is convenient for clinical and pharmacy dispensing.